BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

788 related articles for article (PubMed ID: 14533233)

  • 1. Treatment for substance abuse in Australia: a comparison of public and private programs.
    McNeese-Smith DK
    Int J Psychiatr Nurs Res; 2003 Sep; 9(1):1025-38. PubMed ID: 14533233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ownership differences in the provision of outpatient substance abuse services.
    Burke AC; Rafferty JA
    Adm Soc Work; 1994; 18(3):59-91. PubMed ID: 10138940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managed care and the quality of substance abuse treatment.
    Shepard DS; Daley M; Ritter GA; Hodgkin D; Beinecke RH
    J Ment Health Policy Econ; 2002 Dec; 5(4):163-74. PubMed ID: 14578550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public substance abuse and managed behavioral healthcare. American Managed Behavioral Healthcare Association and National Association of State Alcohol and Drug Abuse Directors, Inc.
    Behav Healthc Tomorrow; 1999 Feb; 8(1):25-30. PubMed ID: 10346117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effectiveness of residential versus outpatient aftercare for parolees from prison-based therapeutic community treatment programs.
    Burdon WM; Dang J; Prendergast ML; Messina NP; Farabee D
    Subst Abuse Treat Prev Policy; 2007 May; 2():16. PubMed ID: 17504540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shifting sands: assessing the balance between public, private not-for-profit and private for-profit physical therapy delivery in Ontario, Canada.
    Landry MD; Williams AP; Verrier MC; Holyoke P; Zakus D; Deber RB
    Physiother Res Int; 2008 Sep; 13(3):189-99. PubMed ID: 18613287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public sector managed care: a comparative evaluation of substance abuse treatment in three counties.
    Beattie M; McDaniel P; Bond J
    Addiction; 2006 Jun; 101(6):857-72. PubMed ID: 16696630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Philadelphia's community based drug abuse program: broader medical and social concepts.
    Schut J
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):286-91. PubMed ID: 1167235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimensions of publicness and performance in substance abuse treatment organizations.
    Heinrich CJ; Fournier E
    J Policy Anal Manage; 2004; 23(1):49-70. PubMed ID: 14976993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing methadone medical maintenance in community-based clinics: disseminating evidence-based treatment.
    King VL; Burke C; Stoller KB; Neufeld KJ; Peirce J; Kolodner K; Kidorf M; Brooner RK
    J Subst Abuse Treat; 2008 Oct; 35(3):312-21. PubMed ID: 18294805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public-private partnership in tuberculosis control: experience in Hyderabad, India.
    Murthy KJ; Frieden TR; Yazdani A; Hreshikesh P
    Int J Tuberc Lung Dis; 2001 Apr; 5(4):354-9. PubMed ID: 11334254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The substance abuse treatment system in the U.S. What is it? What does it do? Myths and misconceptions.
    Rawson RA; Obert JL
    Occup Med; 2002; 17(1):27-39, iii-iv. PubMed ID: 11726334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental health care roles of non-medical primary health and social care services.
    Mitchell P
    Health Soc Care Community; 2009 Feb; 17(1):71-82. PubMed ID: 18700871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Issues for sustainability of non-government organisations in the alcohol and other drugs sector.
    Spooner C; Dadich A
    Drug Alcohol Rev; 2010 Jan; 29(1):47-52. PubMed ID: 20078682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engaging primary health care workers in drug and alcohol and mental health interventions: challenges for service delivery in rural and remote Australia.
    Allan J
    Aust J Prim Health; 2010; 16(4):311-8. PubMed ID: 21138699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug treatment services: funding and admissions.
    Butynski W
    NIDA Res Monogr; 1991; 106():20-52. PubMed ID: 1656262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.